WADA – World Anti-Doping Agency
Montreal, 1 January 2019 – The World Anti-Doping Agency (WADA) refers to its media release of 21 December 2018, which announced that a five-person WADA expert team, led by independent expert Dr. José Antonio (Toni) Pascual, had returned from its mission to Russia without having accessed the Laboratory Information Management System (LIMS) and the underlying data from the former Moscow Laboratory.
Today (1 January 2019), WADA confirms that since the Agency issued that release, no further missions to Russia have been carried out. Accordingly, the 31 December 2018 deadline – by which time the Russian authorities had to provide access to the data – has elapsed without the data having been retrieved. The deadline was one of two conditions stipulated in WADA’s 20 September Executive Committee (ExCo) decision regarding the Russian Anti-Doping Agency’s (RUSADA’s) compliance with the World Anti-Doping Code (Code).
WADA President Sir Craig Reedie said: “I am bitterly disappointed that data extraction from the former Moscow Laboratory has not been completed by the date agreed by WADA’s ExCo in September 2018. Since then, WADA has been working diligently with the Russian authorities to meet the deadline, which was clearly in the best interest of clean sport. The process agreed by WADA’s ExCo in September will now be initiated.”
In keeping with the process that was outlined by the ExCo in September 2018:
This week, Dr. Pascual’s formal mission report, along with all other relevant information and documentation, will be sent to the independent Compliance Review Committee (CRC) for consideration;
On 14-15 January 2019, the CRC will meet and review all available elements. The CRC will provide a recommendation to the WADA Executive Committee based on the applicable rules, namely the International Standard for Code Compliance by Signatories (ISCCS), which entered into force on 1 April 2018, and the Code; and
As soon as practicable thereafter, the CRC’s recommendation will be considered by the ExCo.
Under the ISCCS, if the CRC recommends non-compliance, and the ExCo agrees with it, RUSADA will have the right to challenge that assertion to the Court of Arbitration for Sport (CAS), who will hear the case and take the final decision.
WADA has now written to Russia’s Minister of Sport, Pavel Kolobkov, and the Director General of RUSADA, Yury Ganus, to officially notify them of the situation and to remind them of the next steps in the process.
Given the importance for clean sport of access to, and subsequent authentication and analysis of, the data from the former Moscow Laboratory in order to build strong cases against cheats and exonerate other athletes, WADA experts continue to be ready to proceed with extraction of the data should the issue reported upon on 21 December be resolved by the Russian authorities. WADA will update the CRC of any progress in this regard at the CRC 14-15 January 2019 meeting.
WADA also continues its work with RUSADA, including through the presence of a WADA-commissioned Independent International Expert at RUSADA’s headquarters, to ensure that proper anti-doping activities, in particular testing, are being carried out in Russia.
Montreal, 1 January 2019 – The World Anti-Doping Agency (WADA) announces that its 2019 List of Prohibited Substances and Methods (List), which was first published on 28 September 2018, enters into force today (1 January).
The List, which is one of six International Standards that are mandatory for all Signatories of the World Anti-Doping Code (Code), designates what substances and methods are prohibited both in- and out-of-competition, and which substances are banned in particular sports.
The List’s annual revision process is led by WADA, beginning with an initial meeting in January and concluding with the publication of the List by 1 October. This is an extensive consultation process that includes WADA’s List Expert Group gathering information, circulating a draft List among stakeholders, taking their submissions into consideration and revising the draft, followed by review by the Agency’s Health, Medical and Research (HMR) Committee.
The HMR Committee then makes its recommendation to the WADA Executive Committee, which approves the List during its September meeting.
For a substance or method to be added to the List, it must be determined that it meets two of the following three criteria:
It has the potential to enhance or enhances sport performance
It represents an actual or potential health risk to the athletes
It violates the spirit of sport
It should be noted that for athletes who have a legitimate medical reason for using a prohibited substance or method that is on the List, they may be accommodated if they meet the criteria outlined in the International Standard for Therapeutic Use Exemptions (ISTUE). The TUE process has overwhelming acceptance from athletes, physicians and anti-doping stakeholders worldwide.
To view the changes made in the 2019 Prohibited List as compared to the 2018 version, please see the 2019 Summary of Major Modifications and Explanatory Notes.
Languages and Formats
The 2019 Prohibited List; the 2019 Summary of Modifications and Explanatory Notes; and the 2019 Monitoring Program are available for download on WADA’s website in multiple languages.
Stakeholders wishing to translate the List into other languages are kindly asked to signal their interest to firstname.lastname@example.org. If interested, WADA would provide the necessary files and, once the translation is finalized, would make the List available on the Agency’s website.
The List’s mobile-friendly digital edition can be accessed here.
WADA ENGAGES COVINGTON & BURLING LLP TO FURTHER INVESTIGATE ALLEGATIONS OF IMPROPER CONDUCT
Montreal, 3 January 2019 – The World Anti-Doping Agency (WADA) announces that it has engaged the law firm of Covington & Burling LLP to further investigate allegations of bullying and harassment within the organization, including allegations concerning conduct by members of the Agency’s Executive Committee (ExCo) during its meeting in the Seychelles in September 2018.
As communicated on 15 November 2018 following WADA’s ExCo and Foundation Board meetings in Azerbaijan, allegations of improper conduct by ExCo members during the Agency’s September 2018 meeting were discussed extensively by the ExCo in Azerbaijan; and, as part of that discussion, the initial findings of an external, independent review commissioned by WADA were presented.
The ExCo determined that, given the seriousness of the allegations, a further investigation should be carried out, and that WADA should seek legal advice to help in determining a path forward. Further to these decisions, Covington has been given the mandate to conduct a full and thorough investigation of allegations of bullying and harassment, including interviews of the relevant parties; and, to deliver unbiased and independent findings to the ExCo. Covington has a distinguished reputation for handling sensitive investigations, including those involving workplace conduct for a variety of entities ranging from multinational companies to educational institutions.
Covington’s advice is also being sought with respect to a broader, more general investigation of the organization’s culture, which was discussed by the ExCo in November 2018. While the ExCo did not conclude that it was merited at the time based on the information at its disposal, the ExCo determined that the Agency would seek legal advice on the matter.
WADA will provide a further update following the conclusion of the investigation.
Montreal, 20 December 2018
The World Anti-Doping Agency (WADA) is pleased to publish the following updated templates for use by Anti-Doping Organizations (ADOs) in carrying out their programs and activities. These templates have been updated to reflect changes to the International Standard for the Protection of Privacy and Personal Information (ISPPPI), which took effect in June this year:
Doping Control Form (and instructions)
Therapeutic Use Exemption (TUE) Application Form
Athlete Information Notice
Athlete Consent Form
The updated templates detail the personal information processed for anti-doping purposes, state the legal bases for such processing and specify the rights of participants in respect of their personal information.
Please note that the TUE Application Form will be mandatory for all ADOs starting on 1 January 2019, pursuant to the revised International Standard for Therapeutic Use Exemptions (ISTUE), which will be published in the coming days and that will come into force on 1 January 2019.
We hope that these templates facilitate delivery of quality anti-doping programs.
Should you have any questions regarding these templates, please feel free to contact email@example.com.
World Anti-Doping Agency
Montreal, 19 December 2018
Further to our communication of 29 November, the World Anti-Doping Agency (WADA) wishes to remind you that online registration is now open for the 15th edition of its Annual Symposium, which will be held on Wednesday, 13 March and Thursday, 14 March 2019 at the SwissTech Convention Center in Lausanne, Switzerland. Contrary to recent years, the Symposium will be a two-day event versus three in light of WADA’s World Conference on Doping in Sport that will be held in November 2019, in Katowice, Poland.
The WADA Symposium, which is the main event on the annual global anti-doping calendar, is a unique and practical event that offers anti-doping stakeholders the opportunity to gather, interact and learn from one another. The Symposium is designed for anti-doping practitioners from International Federations, National and Regional Anti-Doping Organizations and Major Event Organizations; representatives from Governments, Athlete Commissions, WADA-accredited laboratories and Athlete Passport Management Units; as well as, other stakeholders such as the media, researchers and service providers that are integral to clean sport.
Under the theme “Towards 2021 – Navigating the future together”, this year's agenda will focus on the 2021 World Anti-Doping Code (Code) and International Standards review as we head towards the World Conference. The event will also address the Anti-Doping Charter of Athletes’ Rights that is being developed by WADA’s Athlete Committee with the aim of including key principles within the 2021 Code.
WADA warmly welcomes the participation of athlete representatives (who will participate for free). Under the leadership of WADA’s Athlete Committee, a one-and-a-half-day session will be held that will be exclusively dedicated to athlete representatives, which will cover the Anti-Doping Charter of Athletes’ Rights; and, other key topics such as the new ADAMS and other matters that directly relate to an athlete’s experience with anti-doping. In order to maximize the athletes’ voice, Anti-Doping Organization stakeholders are asked to encourage the participation of their athlete representatives.
Should you wish to register for the Symposium, please do so on the Symposium Website by 26 February 2019. The website contains all relevant information regarding the event, including the draft Agenda, how to register and how to book your hotel accommodations.
WADA looks forward to welcoming participants in March, in Lausanne, for what promises to be a pivotal event that will lead to positive outcomes for clean sport.
World Anti-Doping Agency
Montreal, 12 December 2018
The World Anti-Doping Agency (WADA) is pleased to publish new Privacy Protection Guidelines.
These Guidelines are designed to assist Anti-Doping Organizations in the implementation of the requirements of the revised International Standard for the Protection of Privacy and Personal Information (ISPPPI), which took effect in June this year.
The Guidelines outline the requirements of the ISPPPI and include several new practical tools and templates, namely:
A form of record of processing;
A confidentiality agreement template;
A security breach reporting form; and
A risk assessment form
Consistent with the ISPPPI, these Guidelines aim to provide a minimum, common set of standards for the appropriate treatment of personal information processed in the course of anti-doping activities. The Guidelines are a Level III, non-mandatory document.
For any questions or to provide feedback relating to the Guidelines, please direct your e-mails to firstname.lastname@example.org.
World Anti-Doping Agency
An introduction and overview on Anti-Doping.
What is Doping
According to the CPISRA Anti Doping Rules compliant to WADA Code, Doping is defined as:
- Presence of a prohibited Substance or its metabolites or markets , as defined in the WADA Prohibited List in an athlete’s bodily specimen, except when in agreement with a TUE granted for the particular substance.
- Use or attempted use of a Prohibited Substance or Methods.
- Tampering or attempting to temper with any part of Doping Control.
- Violation of applicable requirements regarding Athlete availability for Out-of-Competition Testing for RTP (Registered Testing Pool) athletes.
- Possession or trafficking of Prohibited Substances and Methods.
- Administration or attempted administration of a Prohibited Substance or Method to any athlete , or assisting ,encouraging ,aiding , abetting , covering up or any other type of complicity involving an anti-doping rule.
- Administration or Attempted Administration to any Athlete In-Competition of any Prohibited Substance or Prohibited Method, or Administration or Attempted Administration to any Athlete Out-of-Competition of any Prohibited Substance or any Prohibited Method that is Prohibited Out-of-Competition
–Complicity : Assisting, encouraging, aiding, abetting, conspiring, covering up or any other type of intentional complicity involving an anti-doping rule violation.
–Prohibited Association : Association by an Athlete or other Person subject to the authority of an Anti-Doping Organization in a professional or sport-related capacity with any ineligible Athlete / Support Person because of an Anti-Doping rule Violation or equivalent case.
Why is Doping Prohibited
The sports regulations prohibit Doping. Any violation of this rules, be it voluntary or not, constitutes a failure to respect the principle of equal opportunities and, therefore, a disrespect of the sports ethics.
Moreover, the consumption of substances which improve performances can put health in danger. The athlete who has resort to Doping doesn’t harm only himself but he also negatively affects sports as a whole.
What are the tasks of the CPISRA Anti-Doping Committee
In 2005, CPISRA constituted a Committee for the fight against Doping charged of the execution of controls and the surveillance of the tests. This committee is responsible for education of CP athletes concerning anti doping, for the conception and the respect of the anti doping rules, for the diffusion of the Prohibited list , for the formation and perfection of the controllers and also the provision information and advice. Its activities are defined through the Anti Doping Committee Statue.
What about medicines provided on order?
The athlete who must follow a treatment should draw the attention of his/her physician and/or pharmacist to the list of the relevant Doping substances.
If he/she obtains medicines from abroad, he/she must take care of their composition which is mentioned on the note devoted to the patients. The ideal would be to carry away his/her own medicines.
Each athlete should establish, with the help of his/her physician or pharmacist, a personal list of the medicines that he can consume in case of illness- personal medication notebook, this would prevent him from absorbing prohibited substances involuntarily.
The Therapeutic Use Exemption (TUE)
A TUE may be granted to an Athlete permitting the use of Prohibited Substance or Prohibited Methods as defined by the Prohibited List for the following reasons:
-The Athlete would experience a significant impairment to health if the Prohibited Substance or Prohibited Method would produce no additional enhancement of performance other than that which might be anticipated by a return to a state of usual health following the treatment of a legitimate medical condition.
-There is no reasonable therapeutic alternative to the Use of the otherwise Prohibited Substance or Prohibited Method.
-The necessity for the Use of the otherwise Prohibited Substance or Prohibited Method cannot be a consequence , wholly or in part , of the prior non –therapeutic Use of substances from the Prohibited List.
How long do the medicines remain detectable in urine?
What is an anti-doping control?
An anti-doping control consists in analyzing, by accredited laboratories, the urine or blood withdrawals of selected athletes in order to track down the prohibited substances. The discovery of such substances results in tacking disciplinary measures against the athlete. Anti-doping control assures the respect of equal opportunities in competition.
Who is submitted to the controls
Who is responsible for anti-doping controls?
Who is in charge of controls?
During the controls, what about disabled athletes?
What does it occur to urine (or blood) withdrawals?
Are the sample of urine (or blood) safe from manipulation?
Are the tests unfailing?
What happens when the result of controls it is negative?
What happens when the result of controls is positive?
The results of Out of competition testing are announced directly by the CPISRA Anti Doping Committee to the athlete.
The athlete can ask in writing for an analysis of the sample B. He has the right to attend this analysis accompanied by an expert and /or a trustworthy person. If the result is negative, the control is declared negative. On the other hand, if the result confirms the one gotten from sample A, the control is declared positive.
The possible sanctions are decided according the CPISRA anti doping rules and applied by the federation of the relevant athlete. Before, the athlete has the right to express himself and to have knowledge of the file. The case must remain confidential until the first instance decision.
It is possible to protest a first instance decision. The protest can be forwarded to an unbiased arbitration court, like WADA and Sport Arbitrary Tribunal in Lausanne.